Effect of Salivary Phosphate-Binding Chewing Gum on Serum Phosphate in Chronic Kidney Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nephron Clinical Practice

• Publication date

  2013-06-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000351850PMID 23797006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study.

  2013cited by this paper
• Effects of phosphate binders in moderate CKD.

  2012cited by this paper
• Salivary glands: a new player in phosphorus metabolism.

  2011cited by this paper
• Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease.

  2011cited by this paper
• Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.

  2011cited by this paper
• Serum phosphate and mortality in patients with chronic kidney disease.

  2010cited by this paper
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

  2009cited by this paper
• Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.

  2009cited by this paper
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

  2009cited by this paper
• Sulfated chitin and chitosan as novel biomaterials.

  2007cited by this paper
• Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease

  2005cited by this paper
• The modification of diet in renal disease study.

  1989cited by this paper

• Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

  2025cites this paper
• A Review on Profit, Probable Hazard, and Ecological Impacts of Commonly used Chewing Gum

  2021cites this paper
• Association of obesity and muscle mass with risk of albuminuria in renal transplant recipients

  2020cites this paper
• Effect of Sugar Free Chewing Gum as a Supplemental Approach Instructions to Control Serum Phosphorus Level among Hemodialysis Patients

  2019cites this paper
• Systemic network for dietary inorganic phosphate adaptation among three organs

  2018cites this paper
• Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

  2018cites this paper
• Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes

  2018cites this paper
• A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain

  2018cites this paper
• Correlation between calcium and phosphate levels to calculus accumulation on coronary heart disease patients

  2017cites this paper
• Palliative Nephrology: Time for New Insights.

  2017cites this paper
• Effects of Expelling of Induced Hypersalivation on Serum Phosphorus, Urea and Creatinine Levels in End Stage Renal Disease Patients

  2017cites this paper
• A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

  2017cites this paper
• Phosphate binders in chronic kidney disease: a systematic review of recent data

  2016cites this paper
• An Update on Phosphate Binders: A Dietitian's Perspective.

  2016cites this paper
• Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide

  2016cites this paper
• Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification

  2016cites this paper
• Acinetobacter haemolyticus MG606 produces a novel, phosphate binding exobiopolymer.

  2015cites this paper
• Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease

  2015cites this paper
• 2012 ERA-EDTA Registry Annual Report: cautious optimism on outcomes, concern about persistent inequalities and data black-outs

  2015cites this paper
• Enhanced Production of Microbial Exocellular Biopolymers for Removal of Phosphate from Water

  2015cites this paper
• Impact of Weaning from Acute Dialytic Therapy on Outcomes of Chronic Kidney Disease following Urgent-Start Dialysis

  2015cites this paper
• Dietary interventions for mineral and bone disorder in people with chronic kidney disease.

  2015cites this paper
• Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age

  2015cites this paper
• Maintenance Dialysis throughout the World in Years 1990 and 2010.

  2015cites this paper
• Fracture risk and mortality post‐kidney transplantation

  2015cites this paper
• Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients.

  2015cites this paper
• Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus

  2014cites this paper
• Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.

  2014cites this paper
• Noncardiovascular mortality in CKD: an epidemiological perspective

  2014cites this paper
• Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?

  2014cites this paper
• What can we learn from the saga of chitosan gums in hyperphosphatemia therapy?

  2014cites this paper
• Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial

  2014cites this paper
• The future of phosphate binders: a perspective on novel therapeutics

  2014cites this paper